These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 39067874)

  • 1. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tertiary lymphoid structures in cancer.
    Schumacher TN; Thommen DS
    Science; 2022 Jan; 375(6576):eabf9419. PubMed ID: 34990248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis.
    Zhao YY; Fan Z; Tao BR; Du ZG; Shi ZF
    J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39067874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
    Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
    Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
    Front Immunol; 2022; 13():868155. PubMed ID: 35664009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
    Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q
    J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune cells within tertiary lymphoid structures are associated with progression-free survival in patients with locoregional recurrent breast cancer.
    Gu J; Wang J; Sun Y; Mao X; Qian C; Tang X; Wang J; Xie H; Ling L; Zhao Y; Liu X; Zhang K; Pan H; Wang S; Wang C; Zhou W
    Cancer Med; 2024 Jan; 13(1):e6864. PubMed ID: 38133211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution and maturation of tertiary lymphoid structures can predict clinical outcomes of patients with gastric adenocarcinoma.
    Sun H; Liu Y; Cheng W; Xiong R; Gu W; Zhang X; Wang X; Wang X; Tan C; Weng W; Zhang M; Ni S; Huang D; Xu M; Sheng W; Wang L
    Front Immunol; 2024; 15():1396808. PubMed ID: 39136032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment
    Xu W; Lu J; Liu WR; Anwaier A; Wu Y; Tian X; Su JQ; Qu YY; Yang J; Zhang H; Ye D
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8
    Giles JR; Globig AM; Kaech SM; Wherry EJ
    Immunity; 2023 Oct; 56(10):2231-2253. PubMed ID: 37820583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy.
    Wang Q; Sun K; Liu R; Song Y; Lv Y; Bi P; Yang F; Li S; Zhao J; Li X; Chen D; Mei J; Yang R; Chen K; Liu D; Tang S
    Clin Transl Med; 2023 Aug; 13(8):e1346. PubMed ID: 37525587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas.
    Kinker GS; Vitiello GAF; Diniz AB; Cabral-Piccin MP; Pereira PHB; Carvalho MLR; Ferreira WAS; Chaves AS; Rondinelli A; Gusmão AF; Defelicibus A; Dos Santos GO; Nunes WA; Claro LCL; Bernardo TM; Nishio RT; Pacheco AM; Laus AC; Arantes LMRB; Fleck JL; de Jesus VHF; de Moricz A; Weinlich R; Coimbra FJF; de Lima VCC; Medina TDS
    Gut; 2023 Oct; 72(10):1927-1941. PubMed ID: 37230755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer.
    Parra ER; Zhang J; Jiang M; Tamegnon A; Pandurengan RK; Behrens C; Solis L; Haymaker C; Heymach JV; Moran C; Lee JJ; Gibbons D; Wistuba II
    Nat Commun; 2023 Apr; 14(1):2364. PubMed ID: 37185575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience.
    Travers SS; Fisher CM; Kabos P; Cittelly DM; Ormond DR
    J Neurooncol; 2023 May; 163(1):115-121. PubMed ID: 37131107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database.
    Peiffer DS; Zhao F; Chen N; Hahn OM; Nanda R; Olopade OI; Huo D; Howard FM
    JAMA Oncol; 2023 Apr; 9(4):500-510. PubMed ID: 36821125
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.